These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7480380)

  • 1. Distractibility in schizophrenia.
    Bergman A; O'Brien J; Osgood G; Cornblatt B
    Psychiatry Res; 1995 Jul; 57(2):131-40. PubMed ID: 7480380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography.
    Miller DD; Rezai K; Alliger R; Andreasen NC
    Biol Psychiatry; 1997 Mar; 41(5):550-9. PubMed ID: 9046987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiothixene and trifluoperazine in acutely disturbed schizophrenic patients.
    Ahmad SH; Hasan KZ
    J Pak Med Assoc; 1977 Apr; 27(4):313-6. PubMed ID: 411951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, first-episode psychosis patients.
    Good KP; Rabinowitz J; Whitehorn D; Harvey PD; DeSmedt G; Kopala LC
    Schizophr Res; 2004 May; 68(1):11-9. PubMed ID: 15037335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: a 1-year follow up study.
    Rémillard S; Pourcher E; Cohen H
    Schizophr Res; 2005 Dec; 80(1):99-106. PubMed ID: 16162401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of neuroleptic medication in pervasive developmental disorders of childhood.
    Mikkelsen EJ
    Schizophr Bull; 1982; 8(2):320-32. PubMed ID: 6126001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia.
    Knight RG; Harrison A
    N Z Med J; 1979 Apr; 89(634):302-4. PubMed ID: 377155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombocytopenia associated with chlorpromazine, haloperidol and thiothixene: a case report.
    Balon R; Berchou R; Zethelius M
    Can J Psychiatry; 1987 Mar; 32(2):149-50. PubMed ID: 3567823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical antipsychotic drugs improve cognition in schizophrenia.
    Meltzer HY; Sumiyoshi T
    Biol Psychiatry; 2003 Feb; 53(3):265-7; author reply 267-8. PubMed ID: 12559661
    [No Abstract]   [Full Text] [Related]  

  • 10. Tardive tourettism after exposure to neuroleptic therapy.
    Bharucha KJ; Sethi KD
    Mov Disord; 1995 Nov; 10(6):791-3. PubMed ID: 8749999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antipsychotic drugs on memory functions of schizophrenic patients.
    Eitan N; Levin Y; Ben-Artzi E; Levy A; Neumann M
    Acta Psychiatr Scand; 1992 Jan; 85(1):74-6. PubMed ID: 1347670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol.
    Gallhofer B; Jaanson P; Mittoux A; Tanghøj P; Lis S; Krieger S
    Pharmacopsychiatry; 2007 Nov; 40(6):275-86. PubMed ID: 18030652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol.
    Purdon SE; Malla A; Labelle A; Lit W
    J Psychiatry Neurosci; 2001 Mar; 26(2):137-49. PubMed ID: 11291531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol for chronically hospitalized psychotics: a double-blind comparison with thiothixene and placebo; a follow-up open evaluation.
    Howard JS
    Dis Nerv Syst; 1974 Oct; 35(10):458-63. PubMed ID: 17894059
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurocognitive functioning in schizophrenia: a trial of risperidone versus haloperidol.
    Addington J; Addington D
    Can J Psychiatry; 1997 Nov; 42(9):983. PubMed ID: 9429073
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid tranquilization: a comparative study of thiothixene and haloperidol.
    Kelwala S; Ban TA; Berney SA; Wilson WH
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):77-83. PubMed ID: 6145189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book.
    Mishara AL; Goldberg TE
    Biol Psychiatry; 2004 May; 55(10):1013-22. PubMed ID: 15121486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early treatment-induced improvement of negative symptoms predicts cognitive functioning in treatment-naive first episode schizophrenia: a 2-year followup.
    Schuepbach D; Hill SK; Sanders RD; Hell D; Keshavan MS; Sweeney JA
    Schizophr Bull; 2004; 30(4):837-48. PubMed ID: 15957199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis.
    Donohoe G; Owens N; O'Donnell C; Burke T; Moore L; Tobin A; O'Callaghan E
    Eur Psychiatry; 2001 Aug; 16(5):293-8. PubMed ID: 11514132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective, sustained, and shift in attention in patients with diagnoses of schizophrenia.
    Hagh-Shenas H; Toobai S; Makaremi A
    Percept Mot Skills; 2002 Dec; 95(3 Pt 2):1087-95. PubMed ID: 12578247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.